 Dr. Bill Byrom, Ph.D. Perceptive Informatics Senior Director, Product Strategy Visit Website |
Key Areas of Expertise: eClinical (including IVR/IWR, EDC/CDMS, Adaptive Trials, Drug Accountability, Randomization, Trial Supply Management, electronic Patient Reported Outcomes and Integration) & developing new areas of technology applications for clinical trials.
Bill joined Perceptive Informatics (formerly ClinPhone) in July 2000 where he is the senior director of Product Strategy. He holds responsibility for providing strategic direction to Perceptive’s suite of products including developing new areas of technology application within clinical trials and healthcare. Bill joined the pharmaceutical industry in 1991 after completing a PhD in disease control simulation at Strathclyde University, and has worked in a number of roles within Statistics, Clinical Development and International Marketing. Bill is the author of over 50 articles and chapters in professional journals and publications.
|
eSolutions Q&A
-
Has investigator acceptance of electronically managed drug accountability documentation caught up with their comfort level in other trial technologies, such as EDC?Answered October 14th, 2009 by Expert:For clients using EDA in an ongoing manner, sites are absolutely comfortable with the electronic process as it simplifies the workflow and centralizes all drug accountability information. Electronic drug accountability hasn’t yet had the widespread use that EDC now enjoys, so it is difficult to generalize any comparisons to EDC. However we are seeing good adoption and few issues in studies that are using it.
Leave a reply